Chondroitin sulfate as a key molecule in the development of atherosclerosis and cancer progression

Adv Pharmacol. 2006;53:281-95. doi: 10.1016/S1054-3589(05)53013-8.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / therapeutic use
  • Aorta / physiology
  • Atherosclerosis / etiology*
  • Biomechanical Phenomena
  • Chondroitin Sulfate Proteoglycans / chemistry
  • Chondroitin Sulfate Proteoglycans / physiology
  • Chondroitin Sulfates / physiology*
  • Chondroitin Sulfates / therapeutic use
  • Cytokines / physiology
  • Disease Progression
  • Epidermal Growth Factor / metabolism
  • Extracellular Matrix / metabolism
  • Heparin-binding EGF-like Growth Factor
  • Humans
  • Intercellular Signaling Peptides and Proteins
  • Lipoproteins, LDL / metabolism
  • Neoplasms / etiology*
  • Signal Transduction
  • Versicans / physiology

Substances

  • Antineoplastic Agents
  • Chondroitin Sulfate Proteoglycans
  • Cytokines
  • HBEGF protein, human
  • Heparin-binding EGF-like Growth Factor
  • Intercellular Signaling Peptides and Proteins
  • Lipoproteins, LDL
  • oxidized low density lipoprotein
  • Versicans
  • Epidermal Growth Factor
  • Chondroitin Sulfates